Liver and intrahepatic bile ducts-nontumor
Acute graft rejection
Reviewers: Komal Arora, M.D. (see Reviewers page)
Revised: 22 May 2012, last major update May 2012
Copyright: (c) 2004-2012, PathologyOutlines.com, Inc.
● Cell mediated, potentially reversible
● Either resolves or progresses to chronic graft rejection
● Banff International Consensus Document criteria: mixed portal inflammation, cholangiolitis and endothelialitis (Hepatology 1997;25:658, Hepatology 2006;44:489)
● Cautious increase in immunosuppression (even if posttransplant lymphoproliferative disorder)
● Portal infiltrate of lymphocytes and variable eosinophils and neutrophils that damage bile ducts and venous endothelium
● No/minimal hepatocyte damage
● Also loss of bile ducts, arteritis, central ischemic damage with ballooning degeneration and hepatocyte dropout
Moderate acute rejection with bile duct damage
Severe acute rejection
Loss of bile ducts
● EBV associated hepatitis
● Hepatitis C
● Primary biliary cirrhosis
● Terbinafine drug reaction
End of Liver and intrahepatic bile ducts-nontumor > Transplantation > Acute graft rejection
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).